Hematopathology
Sebastian Fernandez-Pol, MD, PhD
Clinical Assistant Professor of Pathology (Hematopathology)
Co-Director, Hematopathology Fellowship Program
Co-Director, Immunopathology Laboratory
Dr. Sebastian Fernandez-Pol is an academic hematopathologist with fellowship training in hematopathology and dermatopathology. He has a particular interest in improving diagnostic accuracy for cutaneous lymphoproliferative disorders. Dr. Fernandez-Pol received his B.A. in chemistry with a concentration in biochemistry from the Washington University in St. Louis in 2003, his MD and PhD from Northwestern University in 2013, and completed his anatomic pathology and clinical pathology residency, hematopathology fellowship, and dermatopathology fellowship at Stanford University in 2019.
Lawrence ‘Tim’ Goodnough, MD
Professor of Pathology and Medicine (Hematology)
Lawrence Tim Goodnough, MD is Professor of Pathology and Medicine (Hematology) in the Departments of Pathology and Medicine, at Stanford University.
Dr. Goodnough received his medical degree in 1975 from the University of Pennsylvania, completed an internship and residency in Internal Medicine at the University of Alabama Hospitals in Birmingham, Alabama, and a fellowship in Hematology/Oncology at Case Western Reserve University (CWRU). He is board certified in Medicine, Hematology, and Oncology; and has an American College of Pathology Certification in Blood Banking.
In his fellowship at CWRU, Dr. Goodnough specialized in coagulation research and later focused on Transfusion Medicine as a specialty that embraces the fields of Blood Banking, Coagulation, and Hematology.
Dita Gratzinger, MD, PhD
Professor of Pathology
Director, Hematopathology
Dr. Dita Gratzinger is a hematopathologist who is dedicated to excellent patient care, to educating the hematopathologists of tomorrow, and to improving both by harnessing strengths across institutional and disciplinary lines. Dr. Gratzinger studies the architecture of supporting cells in the microenvironment as well as diagnosis of lymphoma on small volume specimens, and has a special interest in the role of patient-specific factors in manifestation of hematolymphoid disease, including immunodeficiency and dysregulation-related lymphoid proliferations. She is the founding chair of a multi-institutional consortium, the Cyto-Heme Interinstitutional Collaborative, which brings together hematopathologists, cytopathologists, and oncologists to optimize the benefits of small volume biopsy to lymphoma patients. She also heads the Stanford hematopathology service. Dr. Gratzinger received her B.A. from the University of California at Berkeley, her M.D. and PhD from Yale University, and completed her anatomic pathology residency, surgical pathology fellowship, and hematopathology fellowship at Stanford University.
Jason Kurzer, MD, PhD
Clinical Assistant Professor (Hematopathology)
Director, Clinical Hematology Laboratory
Dr. Jason Kurzer's clinical focus is on Hematopathology, Clinical hematology laboratory management, Clinical Pathology, and Anatomic Pathology.
Yasodha Natkunam, MD, PhD
Professor of Pathology,
Ronald F. Dorfman, MBBch, FRCPath Professor in Hematopathology
Co-Director, Immunopathology Laboratory
Dr. Natkunam is an expert in the diagnosis of hematopoietic tumors including lymphoma and leukemia and has 20-years of experience in the hematopathology diagnostic services of Stanford Health and Stanford Children’s Health. Her research focuses on refining the diagnosis and prognosis of patients with hematopoietic tumors and has furnished novel reagents, diagnostic criteria and guidelines for clinical practice. She currently serves on a number of editorial boards, expert panels and professional societies in her field.
Jean Oak, MD, PhD
Clinical Assistant Professor of Pathology (Hematopathology)
Director, Hematopathology Fellowship Program
Dr. Oak received her MD and PhD from University of California, Irvine, and completed her anatomic pathology and clinical pathology residency, hematopathology fellowship, and transfusion medicine fellowship at Stanford University. Her research and clinical interests include clinical assay development for tumor immunophenotyping, lymphocyte subset monitoring, and immunotherapy target antigen assessment in a variety of hematologic and immunologic disorders. As director of a clinical flow cytometry laboratory, she oversees the design, validation, and implementation of various immunophenotyping assays in addition to ensuring quality assurance and regulatory compliance for CLIA certification.
Dr. Atif Saleem completed his residency training in Anatomic and Clinical Pathology, followed by fellowships in Hematopathology and Dermatopathology at Stanford. He is board certified in both Anatomic Pathology and Clinical Pathology, Hematopathology, and Dermatopathology. His interests include virus-associated neoplasms, medical education, and global health.
Oscar Silva, MD, PhD
Clinical Assistant Professor of Pathology (Hematopathology)
Associate Program Director, Pathology Residency Training (AP)
Oscar is an academic hematopathologist who completed anatomic and clinical pathology residency and hematopathology fellowship at Stanford in 2020. Prior to Stanford, he received his MD and PhD from UCLA. His interests include immunology, the pathogenesis and diagnosis of lymphomas, and global health.
Brent Tan, MD, PhD
Clinical Associate Professor of Pathology, Clinical Hematology
Assistant Director, Clinical Hematology
Associate Director of Quality for Informatics
My primary area of expertise is in the diagnosis of lymphoid and myeloid neoplasms. I am interested in the use of modern molecular techniques as a diagnostic aid as well as in providing prognostic information. My current areas of research focus on these areas.
Albert Tsai, MD, PhD
Assistant Professor of Pathology (Hematopathology)
Dr. Tsai received his undergraduate training at the University of California, Los Angeles (B.S., Biochemistry, summa cum laude), followed by combined medical and graduate training at the University of Southern California (M.D., Ph.D., Biochemistry). He completed anatomic and clinical pathology (AP/CP) residency and hematopathology fellowship at Stanford University, receiving board certification in AP/CP and hematopathology. As an instructor, he performed clinical diagnostic duties on the hematopathology service while doing postdoctoral training in the laboratory of Dr. Sean Bendall, with funding from the Damon Runyon Cancer Research Foundation.
As a physician and hematopathologist, he seeks to mechanistically dissect myelodysplastic syndromes (MDS) using highly-multiplexed immunophenotyping — mass cytometry / cytometry by time-of-flight (CyTOF) and multiplexed ion beam imaging (MIBI). MDS is an especially complex and heterogeneous disease of abnormal blood cell development with increasing prevalence and few treatments. By combining practical experience clinically diagnosing MDS, next generation single cell proteomic approaches, fundamental discoveries in the biology of MDS, and knowledge of clinical laboratory testing, we hope to develop new clinical diagnostics for personalizing MDS therapies and therapeutic monitoring.
His clinical diagnostic duties are on the hematopathology service, primarily in the diagnosis of MDS, leukemias, lymphomas, and other hematopoietic diseases from blood, bone marrow, and tissue samples.
Gerlinde Wernig, MD
Assistant Professor of Pathology
Gerlinde is a pathologist by trade whose research centers around the mechanisms of fibrosis and new treatments. She enjoys staying active by hiking in the mountains and sprinting between clinic and lab. She finds optimizing complex lab protocols as gratifying as perfecting the recipes in her side-gig as an undercover chef.